Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | PTK2B | Q14289 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ALPG | P10696 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Niacinamide SCHEMBL8705607 | 0.78 | SIRT2 (0.56) | NPC1POLBALDH1A1RAB9A | |
| SCHEMBL156347 | 0.72 | NPC1 (0.40) | FDPSNPC1POLBPTK2BALDH1A1 | |
| SCHEMBL28361684 | 0.71 | MMP1 (0.41) | FDPSMMP1MMP2MMP3 | |
| SCHEMBL3482003 | 0.71 | CA2 (0.39) | FDPSNPC1POLBPTK2BALDH1A1 | |
| SCHEMBL7972147 | 0.68 | CCR1 (0.42) | FDPSNPC1POLBPTK2BALDH1A1 | |
| SCHEMBL20379776 | 0.67 | PTK2B (0.42) | NPC1POLBPTK2BALDH1A1RAB9A | |
| SCHEMBL10040009 | 0.64 | NCF1 (0.47) | FDPSNPC1PTK2BALDH1A1RAB9A | |
| SCHEMBL1899085 | 0.64 | FDPS (0.53) | FDPSNPC1POLBPTK2BMMP2 | |
| SCHEMBL23528130 | 0.62 | HDAC1 (0.40) | FDPSALDH1A1 | |
| SCHEMBL31530001 | 0.62 | NAPRT (0.38) | FDPSNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109715824-A | Enzymatic nucleic acid synthesis | 哈佛学院董事及会员团体 | 2019-05-03 | — | — | CN | claimed |
| CN-107460177-A | Using the RNA polymerase mutant of chemically modified nucleoside acid | 张海生 | 2017-12-12 | — | — | CN | claimed |
| CN-102203282-B | Methods and apparatus for measuring analytes using large scale FET arrays | LIFE TECHNOLOGIES CORP | 2014-04-30 | — | — | CN | claimed |
| CN-102203282-A | Methods and apparatus for measuring analytes using large scale fet arrays | LIFE TECHNOLOGIES CORP | 2011-09-28 | — | — | CN | claimed |
| CN-102165077-A | Method for lowering the dependency towards sequence variation of a nucleic acid target in a diagnostic hybridization assay | BIOMERIEUX SA | 2011-08-24 | — | — | CN | claimed |
| US-20020182600-A1 | Method for assaying biological and other constituents using synthetic nucleounits in lateral flow, liquid, and dry chemistry techniques | SMITH JACK V (US) | 2002-12-05 | — | — | US | claimed |
| EP-0076647-A2 | Culture media for cells originating from the immune system | HANA Biologics Incorporated (US) | 1983-04-13 | — | — | EP | claimed |
| WO-2025245512-A1 | METHODS TO SHIFT REDOX EQUILIBRIUM USING AN ORTHOGONAL REDOX COFACTOR, AND APPLICATIONS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-11-27 | — | — | WO | disclosed |
| US-20240398294-A1 | Disposable electrochemical biosensor based on NAD(P)-dependent dehydrogenase and diaphorase | GLAS TRUST COMPANY LLC | 2024-12-05 | — | — | US | disclosed |
| US-20210219876-A1 | Disposable electrochemical biosensor based on NAD(P)-dependent dehydrogenase and diaphorase | NOVA BIOMEDICAL CORPORATION (US) | 2021-07-22 | — | — | US | disclosed |
| US-10626432-B2 | Electron transfer agent | INSIDE BIOMETRICS INTERNATIONAL LIMITED (GB) | 2020-04-21 | — | — | US | disclosed |
| CN-110536967-A | Reagents and methods for analyzing associated nucleic acids | CS GENETICS LTD | 2019-12-03 | — | — | CN | disclosed |
| CN-110430894-A | Immunomodulatory therapeutic MRNA compositions encoding peptides that activate oncogene mutations | MODERNATX INC | 2019-11-08 | — | — | CN | disclosed |
| CN-1090679-C | Monitoring multiple amplification reactions simultaneously and analyzing | PE CORP (US) | 2002-09-11 | — | — | CN | disclosed |
| US-20010019821-A1 | Method for manufacturing and detecting and normalizing HIV for rapid analysis | SMITH JACK V (US) | 2001-09-06 | — | — | US | disclosed |
| CN-1310722-A | Method for marking a ribonucleic acid and resulting marked RNA fragments | BIO MERIEUX (FR) | 2001-08-29 | — | — | CN | disclosed |
| CN-1279610-A | Method for inhibiting development of liver cancer and increasing survival in chronic hepadnavirus infection | CORNELL RES FOUNDATION INC (US) | 2001-01-10 | — | — | CN | disclosed |
| CN-1107892-A | Monitoring multiple amplification reactions simultaneously and analyzing | HOFFMANN LA ROCHE (CH) | 1995-09-06 | — | — | CN | disclosed |
| CN-1057862-A | The mutain of granulocyte colony stimulating factor | BOEHRINGER MANNHEIM GMBH (DE) | 1992-01-15 | — | — | CN | disclosed |
| CN-86102090-A | Method for preparing DNA, RNA, peptide, polypeptide or protein by using recombinant DNA technology | — | 1986-11-05 | — | — | CN | disclosed |